Topic: FierceMedTech Fierce 15 2017
Genomics, bioelectronics and artificial intelligence are clear themes among FierceMedTech's 2017 Fierce 15 companies.
Velano Vascular’s mission is to improve the hospital experience for patients and healthcare providers by reducing the pain and risk associated with drawing blood.
Seventh Sense Biosystems (7SBio) concentrates on revolutionizing blood collection with a device that is easy and painless to use.
Backed by some big names, media-quiet Australian med dev company Saluda Medical is looking to use its closed-loop neuromodulation technology to monitor signals traveling along the spine while also stimulating the body itself.
Recursion Pharmaceuticals looks to step up its artificial intelligence-enabled drug discovery activities and pivot away from the relatively simple job of repurposing meds.
MedyMatch is working on artificial intelligence- and machine learning-based solutions to improve the quality and delivery of healthcare, with the ultimate goal of improving outcomes and driving down costs.
Livongo, a digital health company focused on chronic disease, runs a cloud-based diabetes management program based around a blood glucose meter.
By focusing on novel blood-based assays, data sets and analytics, Guardant Health’s goal is to overcome a number of challenges in the area of cancer care.
Gecko Biomedical debuted its first product, a surgical sealant, in Europe this year. But the startup doesn’t bill itself as a sealant company—it’s a tissue reconstruction company, says CEO Christophe Bancel.
Freenome is one of a clutch of companies racing to develop blood-based screening tests for cancer.